Is bluebird bio, Inc. (BLUE) a Buy, Sell, or Hold?
NASDAQ : BLUE
bluebird bio, Inc. — Insider Trades
$4.97 USD
$0 (0.0%)
- Volume
- 1.25M
- Average Volume
- 576.32K
- Market Capitalization
- $48.67M
- P/E Ratio
- -0.20
- Dividend Yield
- 0.00%
- Price Target
- $12.50
- Year High
- $28.60
- Year Low
- $3.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.48
Insider Activity Summary (Last 12 Months)
Insiders Buying
27
Insiders Selling
38
Amount of Insider Selling
$121.37K
BLUE Insider Buying/Selling by Quarter
BLUE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2025-06-02 | A-Award | 3 | 2025-06-03 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Agwunobi John O | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Agwunobi John O | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Vachon Mark | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Vachon Mark | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Colvin Richard A | officer: Chief Medical Officer | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Colvin Richard A | officer: Chief Medical Officer | 2025-06-02 | A-Award | 3 | 2025-06-03 |
| Colvin Richard A | officer: Chief Medical Officer | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Tita-Reid Najoh | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Tita-Reid Najoh | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Obenshain Andrew | director, officer: President and CEO | 2025-06-02 | A-Award | 3 | 2025-06-03 |
| Obenshain Andrew | director, officer: President and CEO | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Obenshain Andrew | director, officer: President and CEO | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Leiderman Elisabeth | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Leiderman Elisabeth | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Jones-Burton Charlotte | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Jones-Burton Charlotte | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Klima Thomas J | officer: See Remarks | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Klima Thomas J | officer: See Remarks | 2025-06-02 | A-Award | 3 | 2025-06-03 |
| Klima Thomas J | officer: See Remarks | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Sterling O. James | officer: Chief Financial Officer | 2025-06-02 | A-Award | 3 | 2025-06-03 |
| Sterling O. James | officer: Chief Financial Officer | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Leschly Nick | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Leschly Nick | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Leschly Nick | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Paulson Richard A. | director | 2025-05-30 | U-Tender | 3 | 2025-06-03 |
| Paulson Richard A. | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Cloonan Michael | director | 2025-06-02 | D-Return | 3 | 2025-06-03 |
| Colvin Richard A | officer: Chief Medical Officer | 2025-03-03 | S-Sale | 3.9194 | 2025-03-05 |
| Klima Thomas J | officer: See Remarks | 2025-03-03 | S-Sale | 3.9194 | 2025-03-05 |
| Obenshain Andrew | director, officer: President and CEO | 2025-03-03 | S-Sale | 3.9194 | 2025-03-05 |
| Obenshain Andrew | director, officer: President and CEO | 2025-02-10 | A-Award | 0 | 2025-02-12 |
| Klima Thomas J | officer: See Remarks | 2025-02-03 | S-Sale | 7.3925 | 2025-02-05 |
| Colvin Richard A | officer: Chief Medical Officer | 2025-02-03 | S-Sale | 7.3925 | 2025-02-05 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2025-02-03 | S-Sale | 7.3925 | 2025-02-05 |
| Obenshain Andrew | director, officer: President and CEO | 2025-02-03 | S-Sale | 7.3925 | 2025-02-05 |
| Colvin Richard A | officer: Chief Medical Officer | 2025-01-06 | S-Sale | 9.24 | 2025-01-08 |
| Obenshain Andrew | director, officer: President and CEO | 2025-01-06 | S-Sale | 9.24 | 2025-01-08 |
| Obenshain Andrew | director, officer: President and CEO | 2024-12-10 | S-Sale | 0.4173 | 2024-12-12 |
| Colvin Richard A | officer: Chief Medical Officer | 2024-12-10 | S-Sale | 0.4173 | 2024-12-12 |
| Tita-Reid Najoh | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Tita-Reid Najoh | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Leschly Nick | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Leschly Nick | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Paulson Richard A. | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Paulson Richard A. | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Jones-Burton Charlotte | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Jones-Burton Charlotte | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Agwunobi John O | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Agwunobi John O | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Leiderman Elisabeth | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Leiderman Elisabeth | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Vachon Mark | director | 2024-11-06 | A-Award | 0 | 2024-11-08 |
| Vachon Mark | director | 2024-11-06 | A-Award | 0.44 | 2024-11-08 |
| Colvin Richard A | officer: Chief Medical Officer | 2024-09-30 | A-Award | 0 | 2024-10-02 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2024-09-30 | A-Award | 0 | 2024-10-02 |
| Sterling O. James | officer: Chief Financial Officer | 2024-09-30 | A-Award | 0 | 2024-10-02 |
| Cloonan Michael | director | 2024-09-30 | A-Award | 0 | 2024-10-02 |
| Klima Thomas J | officer: See Remarks | 2024-09-30 | A-Award | 0 | 2024-10-02 |
| Klima Thomas J | officer: See Remarks | 2024-09-30 | S-Sale | 0.5257 | 2024-10-02 |
| Obenshain Andrew | director, officer: President and CEO | 2024-09-30 | A-Award | 0 | 2024-10-02 |
| Obenshain Andrew | director, officer: President and CEO | 2024-09-30 | S-Sale | 0.5253 | 2024-10-02 |
| Sterling O. James | officer: Chief Financial Officer | 2024-07-01 | A-Award | 0.98 | 2024-07-03 |
| Cloonan Michael | director | 2024-06-20 | A-Award | 0.85 | 2024-06-24 |
| Cloonan Michael | 2024-06-20 | 0 | 2024-06-24 | ||
| Sterling O. James | 2024-06-10 | 0 | 2024-06-13 | ||
| Klima Thomas J | officer: See Remarks | 2024-06-03 | S-Sale | 0.9719 | 2024-06-04 |
| Colvin Richard A | officer: Chief Medical Officer | 2024-03-01 | A-Award | 1.56 | 2024-03-05 |
| Colvin Richard A | officer: Chief Medical Officer | 2024-03-01 | S-Sale | 1.5276 | 2024-03-05 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2024-03-01 | A-Award | 1.56 | 2024-03-05 |
| Obenshain Andrew | director, officer: President and CEO | 2024-03-01 | A-Award | 1.56 | 2024-03-05 |
| Obenshain Andrew | director, officer: President and CEO | 2024-03-04 | S-Sale | 1.5276 | 2024-03-05 |
| Krawtschuk Christopher | officer: Chief Financial Officer | 2024-03-01 | A-Award | 1.56 | 2024-03-05 |
| Klima Thomas J | officer: See Remarks | 2024-03-01 | A-Award | 1.56 | 2024-03-05 |
| Klima Thomas J | officer: See Remarks | 2024-03-04 | S-Sale | 1.5276 | 2024-03-05 |
| Klima Thomas J | officer: See Remarks | 2024-02-05 | S-Sale | 0.9025 | 2024-02-06 |
| Vittiglio Joseph | officer: Chief Business & Legal Officer | 2024-02-05 | S-Sale | 0.9025 | 2024-02-06 |
| Obenshain Andrew | director, officer: President and CEO | 2024-02-05 | S-Sale | 0.9025 | 2024-02-06 |
| Obenshain Andrew | director, officer: President and CEO | 2024-01-05 | S-Sale | 1.4294 | 2024-01-09 |
| Colvin Richard A | officer: Chief Medical Officer | 2024-01-05 | S-Sale | 1.415 | 2024-01-09 |
| Krawtschuk Christopher | officer: Chief Financial Officer | 2023-12-06 | S-Sale | 4.5155 | 2023-12-08 |
| Obenshain Andrew | director, officer: President and CEO | 2023-11-03 | S-Sale | 3.1659 | 2023-11-03 |
| Colvin Richard A | officer: Chief Medical Officer | 2023-11-02 | S-Sale | 2.9769 | 2023-11-03 |
| Klima Thomas J | officer: See Remarks | 2023-09-05 | S-Sale | 3.7886 | 2023-09-06 |
| Obenshain Andrew | director, officer: President and CEO | 2023-08-10 | S-Sale | 3.5416 | 2023-08-10 |
| Tita-Reid Najoh | director | 2023-06-16 | A-Award | 0 | 2023-06-20 |
| Tita-Reid Najoh | director | 2023-06-16 | A-Award | 3.81 | 2023-06-20 |
| Agwunobi John O | director | 2023-06-16 | A-Award | 0 | 2023-06-20 |
| Agwunobi John O | director | 2023-06-16 | A-Award | 3.81 | 2023-06-20 |
| Vachon Mark | director | 2023-06-16 | A-Award | 0 | 2023-06-20 |
| Vachon Mark | director | 2023-06-16 | A-Award | 3.81 | 2023-06-20 |
| Leschly Nick | director | 2023-06-16 | A-Award | 0 | 2023-06-20 |
| Leschly Nick | director | 2023-06-16 | A-Award | 3.81 | 2023-06-20 |
| Leiderman Elisabeth | director | 2023-06-16 | A-Award | 0 | 2023-06-20 |
| Leiderman Elisabeth | director | 2023-06-16 | A-Award | 3.81 | 2023-06-20 |
| Jones-Burton Charlotte | director | 2023-06-16 | A-Award | 3.81 | 2023-06-20 |
| Jones-Burton Charlotte | director | 2023-06-16 | A-Award | 0 | 2023-06-20 |
| Klima Thomas J | officer: See Remarks | 2023-06-02 | S-Sale | 3.499 | 2023-06-06 |